199 related articles for article (PubMed ID: 36229297)
1. Pathogenic variants in TSC2 might cause premature ovarian insufficiency through activated mTOR induced hyperactivation of primordial follicles.
Xu B; Li Z; Li S; Ke H; Zhang Q; Qin Y; Guo T
Fertil Steril; 2022 Dec; 118(6):1139-1149. PubMed ID: 36229297
[TBL] [Abstract][Full Text] [Related]
2. Single-cell RNA-seq identified novel genes involved in primordial follicle formation.
Tan HJ; Deng ZH; Shen H; Deng HW; Xiao HM
Front Endocrinol (Lausanne); 2023; 14():1285667. PubMed ID: 38149096
[TBL] [Abstract][Full Text] [Related]
3. Homozygous missense variant in MEIOSIN causes premature ovarian insufficiency.
Zhang Q; Zhang W; Wu X; Ke H; Qin Y; Zhao S; Guo T
Hum Reprod; 2023 Nov; 38(Supplement_2):ii47-ii56. PubMed ID: 37982418
[TBL] [Abstract][Full Text] [Related]
4. Targeted whole exome sequencing and Drosophila modelling to unveil the molecular basis of primary ovarian insufficiency.
Bestetti I; Barbieri C; Sironi A; Specchia V; Yatsenko SA; De Donno MD; Caslini C; Gentilini D; Crippa M; Larizza L; Marozzi A; Rajkovic A; Toniolo D; Bozzetti MP; Finelli P
Hum Reprod; 2021 Oct; 36(11):2975-2991. PubMed ID: 34480478
[TBL] [Abstract][Full Text] [Related]
5. New strategy for in vitro activation of primordial follicles with mTOR and PI3K stimulators.
Sun X; Su Y; He Y; Zhang J; Liu W; Zhang H; Hou Z; Liu J; Li J
Cell Cycle; 2015; 14(5):721-31. PubMed ID: 25590233
[TBL] [Abstract][Full Text] [Related]
6. Activation of AKT/mammalian target of rapamycin signaling in the peripheral blood of women with premature ovarian insufficiency and its correlation with FMR1 expression.
Rehnitz J; Messmer B; Bender U; Nguyen XP; Germeyer A; Hinderhofer K; Strowitzki T; Capp E
Reprod Biol Endocrinol; 2022 Mar; 20(1):44. PubMed ID: 35248053
[TBL] [Abstract][Full Text] [Related]
7. Genetics, genomics, and genotype-phenotype correlations of TSC: Insights for clinical practice.
Peron A; Au KS; Northrup H
Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):281-290. PubMed ID: 30255984
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Genetic Analysis Results of TSC1/TSC2 Genes in Patients with Clinical Suspicion of Tuberous Sclerosis Complex and Definition of 3 Novel Variants.
Demir S; Yalçıntepe S; Atlı E; Yalçın Y; İkbal Atlı E; Eker D; Karal Y; Gürkan H
Balkan Med J; 2021 Nov; 38(6):341-347. PubMed ID: 34860161
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic variants of meiotic double strand break (DSB) formation genes PRDM9 and ANKRD31 in premature ovarian insufficiency.
Wang Y; Guo T; Ke H; Zhang Q; Li S; Luo W; Qin Y
Genet Med; 2021 Dec; 23(12):2309-2315. PubMed ID: 34257419
[TBL] [Abstract][Full Text] [Related]
10. Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex.
Hoogeveen-Westerveld M; Ekong R; Povey S; Mayer K; Lannoy N; Elmslie F; Bebin M; Dies K; Thompson C; Sparagana SP; Davies P; van Eeghen AM; Thiele EA; van den Ouweland A; Halley D; Nellist M
Hum Mutat; 2013 Jan; 34(1):167-75. PubMed ID: 22903760
[TBL] [Abstract][Full Text] [Related]
11. Whole exome sequencing in a cohort of familial premature ovarian insufficiency cases reveals a broad array of pathogenic or likely pathogenic variants in 50% of families.
Rouen A; Rogers E; Kerlan V; Delemer B; Catteau-Jonard S; Reznik Y; Gompel A; Cedrin I; Guedj AM; Grouthier V; Brue T; Pienkowski C; Bachelot A; Chantot-Bastaraud S; Rousseau A; Simon T; Kott E; Siffroi JP; Touraine P; Christin-Maitre S
Fertil Steril; 2022 Apr; 117(4):843-853. PubMed ID: 35115167
[TBL] [Abstract][Full Text] [Related]
12. Disruption of Tsc2 in oocytes leads to overactivation of the entire pool of primordial follicles.
Adhikari D; Flohr G; Gorre N; Shen Y; Yang H; Lundin E; Lan Z; Gambello MJ; Liu K
Mol Hum Reprod; 2009 Dec; 15(12):765-70. PubMed ID: 19843635
[TBL] [Abstract][Full Text] [Related]
13. Sequence variants of KHDRBS1 as high penetrance susceptibility risks for primary ovarian insufficiency by mis-regulating mRNA alternative splicing.
Wang B; Li L; Zhu Y; Zhang W; Wang X; Chen B; Li T; Pan H; Wang J; Kee K; Cao Y
Hum Reprod; 2017 Oct; 32(10):2138-2146. PubMed ID: 28938739
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the functional and structural characteristics of rare TSC2 variants with clinical and genetic findings.
Dufner Almeida LG; Nanhoe S; Zonta A; Hosseinzadeh M; Kom-Gortat R; Elfferich P; Schaaf G; Kenter A; Kümmel D; Migone N; Povey S; Ekong R; Nellist M
Hum Mutat; 2020 Apr; 41(4):759-773. PubMed ID: 31799751
[TBL] [Abstract][Full Text] [Related]
15. Next-generation sequencing of 500 POI patients identified novel responsible monogenic and oligogenic variants.
Luo W; Ke H; Tang S; Jiao X; Li Z; Zhao S; Zhang F; Guo T; Qin Y
J Ovarian Res; 2023 Feb; 16(1):39. PubMed ID: 36793102
[TBL] [Abstract][Full Text] [Related]
16. AMH mutations with reduced in vitro bioactivity are related to premature ovarian insufficiency.
Alvaro Mercadal B; Imbert R; Demeestere I; Gervy C; De Leener A; Englert Y; Costagliola S; Delbaere A
Hum Reprod; 2015 May; 30(5):1196-202. PubMed ID: 25750103
[TBL] [Abstract][Full Text] [Related]
17. Insulin like growth factor-1-induced phosphorylation and altered distribution of tuberous sclerosis complex (TSC)1/TSC2 in C2C12 myotubes.
Miyazaki M; McCarthy JJ; Esser KA
FEBS J; 2010 May; 277(9):2180-91. PubMed ID: 20412061
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of TSC1 and TSC2 in Danish patients with tuberous sclerosis complex.
Rosengren T; Nanhoe S; de Almeida LGD; Schönewolf-Greulich B; Larsen LJ; Hey CAB; Dunø M; Ek J; Risom L; Nellist M; Møller LB
Sci Rep; 2020 Jun; 10(1):9909. PubMed ID: 32555378
[TBL] [Abstract][Full Text] [Related]
19. Identification of new variants and candidate genes in women with familial premature ovarian insufficiency using whole-exome sequencing.
Morales R; Lledo B; Ortiz JA; Lozano FM; Garcia EM; Bernabeu A; Fuentes A; Bernabeu R
J Assist Reprod Genet; 2022 Nov; 39(11):2595-2605. PubMed ID: 36208357
[TBL] [Abstract][Full Text] [Related]
20. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
Zeng LH; Rensing NR; Zhang B; Gutmann DH; Gambello MJ; Wong M
Hum Mol Genet; 2011 Feb; 20(3):445-54. PubMed ID: 21062901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
